KRAS and non-small cell lung carcinoma: Currently, the molecular characteristics of non-small cell lung cancer (NSCLC) form the basis for clinical diagnosis and treatment of lesions (e.g., EGFR, KRAS), and the phenotypic associations between molecular subtypes and imaging semantic features have been widely studied.